IL143985A0 - New use of melagatran - Google Patents

New use of melagatran

Info

Publication number
IL143985A0
IL143985A0 IL14398500A IL14398500A IL143985A0 IL 143985 A0 IL143985 A0 IL 143985A0 IL 14398500 A IL14398500 A IL 14398500A IL 14398500 A IL14398500 A IL 14398500A IL 143985 A0 IL143985 A0 IL 143985A0
Authority
IL
Israel
Prior art keywords
melagatran
new use
prodrug
inflammation
medicament
Prior art date
Application number
IL14398500A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL143985A0 publication Critical patent/IL143985A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
IL14398500A 1999-01-13 2000-01-13 New use of melagatran IL143985A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9900070A SE9900070D0 (sv) 1999-01-13 1999-01-13 New use
PCT/SE2000/000051 WO2000041716A1 (en) 1999-01-13 2000-01-13 New use of melagatran

Publications (1)

Publication Number Publication Date
IL143985A0 true IL143985A0 (en) 2002-04-21

Family

ID=20414074

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14398500A IL143985A0 (en) 1999-01-13 2000-01-13 New use of melagatran

Country Status (20)

Country Link
US (3) US6683054B1 (xx)
EP (1) EP1150704B1 (xx)
JP (1) JP2002534477A (xx)
KR (1) KR100701539B1 (xx)
CN (1) CN1170592C (xx)
AT (1) ATE319473T1 (xx)
AU (1) AU767077B2 (xx)
BR (1) BR0007452A (xx)
CA (1) CA2356611A1 (xx)
CY (1) CY1107465T1 (xx)
DE (1) DE60026491T2 (xx)
DK (1) DK1150704T3 (xx)
ES (1) ES2257282T3 (xx)
IL (1) IL143985A0 (xx)
NO (1) NO20013414L (xx)
NZ (1) NZ512713A (xx)
PT (1) PT1150704E (xx)
SE (1) SE9900070D0 (xx)
WO (1) WO2000041716A1 (xx)
ZA (1) ZA200105275B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
US6462021B1 (en) * 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
SE0101762D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
DE10133786A1 (de) * 2001-07-16 2003-02-06 Boehringer Ingelheim Pharma Verwendung von Thrombin-Inhibitoren zur Behandlung von Arthritis
SE0103590D0 (sv) * 2001-10-26 2001-10-26 Astrazeneca Ab New Combination
SE0200198D0 (sv) * 2002-01-23 2002-01-23 Astrazeneca Ab New use
SE0203349D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab New use
JP6155187B2 (ja) 2010-03-30 2017-06-28 ヴァーセオン コーポレイション トロンビンの阻害剤としての多置換芳香族化合物
CN108354933A (zh) 2013-03-15 2018-08-03 维颂公司 作为丝氨酸蛋白酶抑制剂的多取代芳族化合物的制药用途
MX2015011567A (es) 2013-03-15 2016-04-25 Verseon Corp Halogeno-pirazoles como inhibidores de trombina.
CA2960790A1 (en) 2014-09-17 2016-03-24 Verseon Corporation Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
LT3261639T (lt) 2015-02-27 2022-11-25 Verseon International Corporation Pakaitiniai pirazolo junginiai kaip serino proteazės inhibitoriai
EP3820564A1 (en) 2018-07-13 2021-05-19 Verseon International Corporation Thrombin inhibitors, formulations, and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6042821A (en) * 1995-11-21 2000-03-28 Smithkline Beecham Corporation Method of treating sepsis with chemokines
TW541316B (en) * 1995-12-21 2003-07-11 Astrazeneca Ab Prodrugs of thrombin inhibitors
SE9600216D0 (sv) * 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
US5669754A (en) * 1996-04-22 1997-09-23 Advanced Dynamics Corporation Ltd. Method and apparatus for collecting plates
SE9601556D0 (sv) 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9603724D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New pharmaceutical parenteral formulation of a thrombin inhibitor
SE9802974D0 (sv) 1998-09-03 1998-09-03 Astra Ab New crystalline forms
AU760735B2 (en) 1998-09-28 2003-05-22 Merck & Co., Inc. A method for treating inflammatory diseases by administering a thrombin inhibitor
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.

Also Published As

Publication number Publication date
JP2002534477A (ja) 2002-10-15
NZ512713A (en) 2004-10-29
EP1150704B1 (en) 2006-03-08
EP1150704A1 (en) 2001-11-07
CN1170592C (zh) 2004-10-13
CA2356611A1 (en) 2000-07-20
DE60026491T2 (de) 2006-11-02
CN1341028A (zh) 2002-03-20
US20080058303A1 (en) 2008-03-06
DE60026491D1 (de) 2006-05-04
DK1150704T3 (da) 2006-06-12
AU2336100A (en) 2000-08-01
BR0007452A (pt) 2001-10-16
KR20010101492A (ko) 2001-11-14
NO20013414D0 (no) 2001-07-10
AU767077B2 (en) 2003-10-30
WO2000041716A1 (en) 2000-07-20
CY1107465T1 (el) 2012-12-19
US20040082518A1 (en) 2004-04-29
ATE319473T1 (de) 2006-03-15
ZA200105275B (en) 2002-09-26
ES2257282T3 (es) 2006-08-01
NO20013414L (no) 2001-07-10
PT1150704E (pt) 2006-06-30
SE9900070D0 (sv) 1999-01-13
US6683054B1 (en) 2004-01-27
KR100701539B1 (ko) 2007-03-30

Similar Documents

Publication Publication Date Title
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
NZ514574A (en) Novel method of treatment
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
MY127126A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
BG106586A (en) Pyrazolopyramidines as therapeutic agents
HK1064921A1 (en) Sustained release formulations of oxymorphone
AU7031500A (en) Therapeutic quinazoline compounds
AU3850600A (en) Dalda analogs and their use
GB0002336D0 (en) Medicaments
MXPA03010761A (es) Combinaciones farmaceuticas.
NZ515339A (en) Use of macrolide compounds for the treatment of dry eye
PL351710A1 (en) Anti−inflammatory therapy for inflammatory mediated infection
NZ514558A (en) Viral treatment
AU5372199A (en) Cyclopentabenzofuran derivatives and their use
ATE360428T1 (de) Analgetisches arzneimittel
AU4133400A (en) Cystic fibrosis medicaments
AU2162202A (en) Antitumor therapy comprising distamycin derivatives
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
MXPA03003980A (es) Uso de melagatran para la elaboracion de un medicamento para el tratamiento de transtornos isquemicos.
AU6846300A (en) Use of cyamemazine for cold turkey benzodiazepine treatment
IL162391A (en) Use of darifenacin in the manufacture of medicaments for reducing urgency in dry overactive bladder patients
AU2002236587A1 (en) Compositions for adhesion prevention
WO2002017905A3 (en) Treatment of burns
MXPA03010350A (es) Uso de un gatran para la elaboracion de un medicamento para el tratamiento de fibrosis pulmonar.